Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of ASP2408”

4 trials

Showing 4 of 4 results

Early research (Phase 1)Study completedNCT02150070
What this trial is testing

Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections

Who this might be right for
Pharmacokinetics of ASP2408Healthy Subjects
Astellas Pharma Global Development, Inc. 32
Early research (Phase 1)Study completedNCT02125435
What this trial is testing

A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP2408
Astellas Pharma Global Development, Inc. 65
Early research (Phase 1)Study completedNCT02052375
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate

Who this might be right for
Rheumatoid ArthritisPharmacokinetics of ASP2408
Astellas Pharma Global Development, Inc. 24
Early research (Phase 1)Study completedNCT02140125
What this trial is testing

Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

Who this might be right for
HealthyPharmacokinetics of ASP2408
Astellas Pharma Inc 24

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation